← Back to Search

Sensor

MicroTrend System for Low Blood Flow

N/A
Waitlist Available
Led By Raul J Gazmuri, MD, PhD
Research Sponsored by ExoStat Medical, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4-6 hours
Awards & highlights

Study Summary

This trial is testing a new system that monitors carbon dioxide levels in the blood, to see if it is safe and effective.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4-6 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4-6 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Correlation between POMCO2

Trial Design

1Treatment groups
Experimental Treatment
Group I: MicroTrend SystemExperimental Treatment1 Intervention
MicroTrend System is placed onto the subject's cheek and the subject will actively participate in the study for up to 6 hours, with up to 4 hours of sensor monitoring.

Find a Location

Who is running the clinical trial?

ExoStat Medical, Inc.Lead Sponsor
Bright Research PartnersIndustry Sponsor
13 Previous Clinical Trials
1,747 Total Patients Enrolled
Raul J Gazmuri, MD, PhDPrincipal InvestigatorCaptain James A. Lovell Federal Health Care Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~3 spots leftby Apr 2025